Hypoglycaemia.
Muneer M.
Adv Exp Med Biol. 2021;1307:43-69. doi: 10.1007/5584_2020_534.
Role of diabetes mellitus on hepatic encephalopathy.
Ampuero J, Ranchal I, del Mar Díaz-Herrero M, del Campo JA, Bautista JD, Romero-Gómez M.
Metab Brain Dis. 2013 Jun;28(2):277-9. doi: 10.1007/s11011-012-9354-2. Epub 2012 Nov 24.
Diabetic Ketoacidosis: Evaluation and Treatment.
Veauthier B, Levy-Grau B.
Am Fam Physician. 2024 Nov;110(5):476-486.
Vitamin A and Diabetes.
Zhang Y, Wang T, Hu X, Chen G.
J Med Food. 2021 Aug;24(8):775-785. doi: 10.1089/jmf.2020.0147. Epub 2020 Nov 24.
Insulin resistance and hepatic steatosis in type 1 diabetes mellitus and their association with diabetic chronic complications.
Popa SG, Simion AM, Soare M, Arcomita D.
Minerva Endocrinol (Torino). 2023 Mar;48(1):27-34. doi: 10.23736/S2724-6507.20.03290-3. Epub 2020 Oct 2.
Pancreatic diabetes mellitus.
Sjoberg RJ, Kidd GS.
Diabetes Care. 1989 Nov-Dec;12(10):715-24. doi: 10.2337/diacare.12.10.715.
BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21.
Zheng H, Zhang X, Li C, Wang D, Shen Y, Lu J, Zhao L, Li X, Gao H.
Microbiome. 2024 Aug 24;12(1):157. doi: 10.1186/s40168-024-01872-3.
The relationship between hepatic enzymes, prediabetes, and diabetes in the Azar cohort population.
Faramarzi E, Mehrtabar S, Molani-Gol R, Dastgiri S.
BMC Endocr Disord. 2025 Feb 14;25(1):41. doi: 10.1186/s12902-025-01871-x.
TRPV1: A novel target for the therapy of diabetes and diabetic complications.
Shen YR, Cheng L, Zhang DF.
Eur J Pharmacol. 2024 Dec 5;984:177021. doi: 10.1016/j.ejphar.2024.177021. Epub 2024 Oct 1.
Dorzagliatin: First Approval.
Syed YY.
Drugs. 2022 Dec;82(18):1745-1750. doi: 10.1007/s40265-022-01813-0.
